AzTrials
AzTrials

Knee OsteoarthritisNCT04960111

Radiostereometry in Knee Arthroplasty

A study testing RSA in people with Knee Osteoarthritis and Knee Arthropathy, run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The innovative aspect of this research is the possibility of combining the data collected with radiostereometric model based Radiostereometry with the data collected through the Galeazzi Institute Registry.This opens the prospect of an earlier identification of patients undergoing prosthetic knee replacement with… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
RSA
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteItaly
Study dates
10 Dec 2019to 10 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age more than 18
  • patients underwent total knee arthroplasty without controindications for this procedure
  • patients enrolled in PatientsReportedOutcomesMeasureS (PROMS) study

Who cannot join

  • age less than 18
  • comorbility that make difficult come back for follow-up
  • patients with allergy at materials used in Radiostereometry tecnique
  • infection
  • anemia, obesity, osteoporosis
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Istituto Ortopedico Galeazzi

    Milan, 20161

    michele ulivi, Dr, 00390266214946, micheleulivi@msn.com

    Recruiting

Other trials in Italy

About this study

Official title: Radiostereometry (Model Based RSA) in the Assessment of Knee Prosthesis Outcome:a Prospective,Pilot,Single-center Study.

The innovative aspect of this research is the possibility of combining the data collected with radiostereometric model based Radiostereometry with the data collected through the Galeazzi Institute Registry.This opens the prospect of an earlier identification of patients undergoing prosthetic knee replacement with initial aseptic loosening.

Being tested
RSA
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RSADevice

    application of tantalium microsphere around knee prosthesis and RSA X-ray post operative to detect early mobilization in follow up.

Study groups in NCT04960111
Study groupRoleWhat they receive
knee arthroplasty with radiostereometry tecniqueExperimentalpatient underwent total knee arthroplasty with insertion of microsphere in tantallium for radiostereometry tecnique.
Receives: Device: RSA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. micro-movement detection with radiostereometry and the patient's perception, measured with Short Form health survey12 at 12 month after surgery.

    evaluate correlation between levels of micro-movement of the prosthetic components using radiostereometry model based RSA and the patient's perception, measured with Short Form health survey12 at 12 month after surgery.

    Measured: 12 months

Secondary outcomes (1)
  1. correlation of micromovements and Patient reported outcomes at follow up

    evaluate correlation between levels of micro-movement of the prosthetic components using radiostereometry model based RSA and the patient's perception, measured with patient reported oucomes used in Galeazzi Institute Registry at each post operative follow-up

    Measured: baseline to 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2021
  2. Study start10 Dec 2019
  3. Primary completion10 Dec 2022 (estimated)
  4. Study completion10 Jul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04960111
Sponsor's protocol ID
RSA
Status last verified
Jul 2021
First submitted
2 Jul 2021
Last updated
19 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing RSA in people with Knee Osteoarthritis and Knee Arthropathy, run by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michele Ulivi (00390266214946, micheleulivi@masn.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

micro-movement detection with radiostereometry and the patient's perception, measured with Short Form health survey12 at 12 month after surgery. (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in